Liposomal Doxorubicin
MCC-15042
Unknown small_molecule terminated
Quick answer
Liposomal Doxorubicin for Ovarian Cancer is a Unknown program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Ovarian Cancer
- Phase
- Unknown
- Modality
- small_molecule
- Status
- terminated